Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kresken

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Der Internist|March 1, 1989
[On the contribution of F. Daschner: "Faulty use of antibiotics and the development of resistance" in Internist, volume 29, issue 5, May 1988, p. 345-6]M Kresken
Pharmazie in Unserer Zeit|September 29, 2001
[How can we protect against broad-band pathogens? The situation with quinolone resistance]M Kresken, D Hafner
Infection|January 1, 1987
[Resistance pattern of clinical bacterial isolates. Results of a super-regional multicenter study of the Resistance Study Committee of the Paul Ehrlich Society of Chemotherapy]M Kresken, B Wiedemann
Antimicrobial Agents and Chemotherapy|August 1, 1988
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacinM Kresken, B Wiedemann
The Journal of Antimicrobial Chemotherapy|October 1, 1986
Development of resistance in the past decade in central EuropeM Kresken, B Wiedemann
The Journal of Antimicrobial Chemotherapy|December 1, 1984
The incidence and development of resistance in Staphylococcus aureus from three European countriesB Wiedemann, M Kresken
Infection|July 8, 2000
Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975-1995. Study Group Bacterial Resistance of the Paul-Ehrlich-Society for ChemotherapyM Kresken, D Hafner
The Journal of Antimicrobial Chemotherapy|June 1, 1990
Prevalence of resistance of aerobic gram-negative bacilli to broad-spectrum antibacterial agents: results of a multicentre studyM Kresken, A Jansen, B Wiedemann
Pneumologie (Stuttgart, Germany)|October 11, 2002
[beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci]J Brauers, S Ewig, M Kresken
International Journal of Antimicrobial Agents|November 9, 2020
Temocillin susceptibility in Enterobacterales with an ESBL/AmpC phenotypeM Kresken, Y Pfeifer, G Werner
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Der Internist|March 1, 1989
[On the contribution of F. Daschner: "Faulty use of antibiotics and the development of resistance" in Internist, volume 29, issue 5, May 1988, p. 345-6]M Kresken
Pharmazie in Unserer Zeit|September 29, 2001
[How can we protect against broad-band pathogens? The situation with quinolone resistance]M Kresken, D Hafner
Infection|January 1, 1987
[Resistance pattern of clinical bacterial isolates. Results of a super-regional multicenter study of the Resistance Study Committee of the Paul Ehrlich Society of Chemotherapy]M Kresken, B Wiedemann
Antimicrobial Agents and Chemotherapy|August 1, 1988
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacinM Kresken, B Wiedemann
The Journal of Antimicrobial Chemotherapy|October 1, 1986
Development of resistance in the past decade in central EuropeM Kresken, B Wiedemann
The Journal of Antimicrobial Chemotherapy|December 1, 1984
The incidence and development of resistance in Staphylococcus aureus from three European countriesB Wiedemann, M Kresken
Infection|July 8, 2000
Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975-1995. Study Group Bacterial Resistance of the Paul-Ehrlich-Society for ChemotherapyM Kresken, D Hafner
The Journal of Antimicrobial Chemotherapy|June 1, 1990
Prevalence of resistance of aerobic gram-negative bacilli to broad-spectrum antibacterial agents: results of a multicentre studyM Kresken, A Jansen, B Wiedemann
Pneumologie (Stuttgart, Germany)|October 11, 2002
[beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci]J Brauers, S Ewig, M Kresken
International Journal of Antimicrobial Agents|November 9, 2020
Temocillin susceptibility in Enterobacterales with an ESBL/AmpC phenotypeM Kresken, Y Pfeifer, G Werner
Pageof 4